Completed OBSERVATIONAL NCT05531188

Efficacy Evaluation and Cutaneous Acceptability of the Lipikar Med Product on Subjects With Atopic Dermatitis

Efficacy Evaluation and Cutaneous Acceptability of the LIPIKAR Med Product on Subjects With Atopic Dermatitis Study Conduct Under Cosmetic Form

Sponsor: Cosmetique Active International

Conditions Atopic Dermatitis

Updated 4 times since 2022 Last updated: Oct 11, 2022 Started: Mar 1, 2021 Primary completion: Nov 3, 2021 Completion: Nov 3, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Atopic Dermatitis, this trial is completed. The trial is conducted by Cosmetique Active International and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Nov 2022 — Jul 2024 [monthly]

Completed
Sep 2022 — Nov 2022 [monthly]

Completed

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cosmetique Active International

Data source: Cosmetique Active International

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Quatre Bornes, Mauritius